SHUYAN LIU: Open Payments
NPI 1427624576 · GLENDORA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 6 payments from 6 companies in 2025. Trend: 2023 $933 · 2024 $1,747 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $121 |
| Genentech USA, Inc. | 1 | $35 |
| Shionogi Inc | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: EMBLAVEO, XIFAXAN, Venclexta, Fetroja, PIFELTRO.
Industry payments across CA — which companies pay providers there.
